Ananda W Goldrath, Michael J Bevan  Immunity 

Slides:



Advertisements
Similar presentations
Volume 17, Issue 9, Pages (November 2016)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 6, Issue 4, Pages (April 1997)
Volume 15, Issue 6, Pages (December 2001)
Peptide Immunization Indicates that CD8+ T Cells are the Dominant Effector Cells in Trinitrophenyl-Specific Contact Hypersensitivity  Stefan Martin, Michael.
Identification of CD3+CD4−CD8− T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD)  Fumi Miyagawa,
Volume 18, Issue 5, Pages (May 2003)
Thymic Selection by a Single MHC/Peptide Ligand
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Following the Development of a CD4 T Cell Response In Vivo
Feedback Regulation of Pathogen-Specific T Cell Priming
Volume 8, Issue 2, Pages (February 1998)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Accelerated Migration of Respiratory Dendritic Cells to the Regional Lymph Nodes Is Limited to the Early Phase of Pulmonary Infection  Kevin L Legge,
Langerin+ Dermal DC, but Not Langerhans Cells, Are Required for Effective CD8- Mediated Immune Responses after Skin Scarification with Vaccinia Virus 
Volume 5, Issue 5, Pages (November 1996)
Volume 17, Issue 2, Pages (August 2002)
Volume 19, Issue 6, Pages (December 2003)
Volume 18, Issue 5, Pages (May 2003)
Accelerated Migration of Respiratory Dendritic Cells to the Regional Lymph Nodes Is Limited to the Early Phase of Pulmonary Infection  Kevin L Legge,
Dynamic Interplay among Monocyte-Derived, Dermal, and Resident Lymph Node Dendritic Cells during the Generation of Vaccine Immunity to Fungi  Karen Ersland,
Designing and Maintaining the Mature TCR Repertoire
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 31, Issue 1, Pages (July 2009)
Volume 18, Issue 3, Pages (March 2003)
Volume 6, Issue 5, Pages (May 1997)
Lck Activity Controls CD4/CD8 T Cell Lineage Commitment
Volume 21, Issue 3, Pages (September 2004)
Volume 45, Issue 1, Pages (July 2016)
Volume 17, Issue 3, Pages (October 2016)
Volume 22, Issue 3, Pages (March 2005)
Volume 29, Issue 6, Pages (December 2008)
Volume 11, Issue 2, Pages (August 1999)
Volume 28, Issue 5, Pages (May 2008)
Cécile Bouneaud, Philippe Kourilsky, Philippe Bousso  Immunity 
CD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Dirk H Busch, Ingrid M Pilip, Sujata Vijh, Eric G Pamer  Immunity 
Volume 15, Issue 3, Pages (September 2001)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Eric A Butz, Michael J Bevan  Immunity 
Volume 29, Issue 5, Pages (November 2008)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 27, Issue 3, Pages (September 2007)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 31, Issue 4, Pages (October 2009)
Volume 17, Issue 5, Pages (November 2002)
Volume 16, Issue 4, Pages (April 2002)
Volume 26, Issue 4, Pages (April 2007)
Volume 17, Issue 9, Pages (November 2016)
Volume 27, Issue 2, Pages (August 2007)
Volume 17, Issue 4, Pages (October 2002)
Susan M. Kaech, Scott Hemby, Ellen Kersh, Rafi Ahmed  Cell 
Volume 32, Issue 1, Pages (January 2010)
Volume 7, Issue 2, Pages (August 1997)
Volume 28, Issue 5, Pages (May 2008)
Volume 12, Issue 3, Pages (March 2000)
Volume 4, Issue 6, Pages (June 1996)
SOCS1 Prevents Potentially Skin-Reactive Cytotoxic T Lymphocytes from Gaining the Ability to Cause Inflammatory Lesions  Galaxia Maria Rodriguez, Dante.
Notch 1 Signaling Regulates Peripheral T Cell Activation
Volume 20, Issue 3, Pages (March 2012)
Volume 25, Issue 1, Pages (July 2006)
Volume 30, Issue 5, Pages (May 2009)
Volume 9, Issue 5, Pages (November 1998)
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Volume 17, Issue 1, Pages (July 2002)
Induction of OVA-specific CTLs by DCs
Memory CD8+ T Cells Undergo Peripheral Tolerance
Volume 7, Issue 4, Pages (October 1997)
Volume 20, Issue 6, Pages (June 2004)
Presentation transcript:

Low-Affinity Ligands for the TCR Drive Proliferation of Mature CD8+ T Cells in Lymphopenic Hosts  Ananda W Goldrath, Michael J Bevan  Immunity  Volume 11, Issue 2, Pages 183-190 (August 1999) DOI: 10.1016/S1074-7613(00)80093-X

Figure 1 Proliferation of Donor Cells in Lymphopenic Hosts Is MHC Class I Dependent CD8+ T cells were enriched from pooled spleen and lymph node of OT-1 or OT-1 Thy1.1+ mice, labeled with CFSE, and 2 × 106 CD8+Vα2+ cells were injected per recipient. Splenocytes from hosts were analyzed 5 days after transfer for detection of CFSE+ donor OT-1 cells by staining with anti-CD8 and anti-Vα2. (A) CFSE expression is shown for OT-1 CD8+Vα2+ cells transferred into unirradiated B6, irradiated B6, or irradiated TAP° hosts. Similar results were observed with OT-1 RAG° donor cells and on days 3 and 6 post transfer in irradiated hosts. (B) CFSE expression is shown for OT-1 Thy1.1+ CD8+Vα2+ cells transferred into untreated B6, Thy1.2-depleted B6, or Thy1.2-depleted TAP° hosts. Immunity 1999 11, 183-190DOI: (10.1016/S1074-7613(00)80093-X)

Figure 2 Expression of ss-Peptide Transgenes (A) Expression of H-2Kb is not upregulated in TAP° mice expressing ss-peptide transgenes. Expression levels of the MHC class I molecule Kb were compared on splenocytes from ss-OVApTAP° (thin black line), ss-R4TAP° (dashed line), ss-VSVTAP° (dotted line), TAP° (bold gray line), and B6 (bold black line) mice. (B) ss-peptide transgenic APC stimulate proliferation of peptide-specific CTL. Filled symbols represent ss-peptide transgene positive and open symbols represent control transgene negative APC. R4-specific CTL were incubated with ss-R4TAP° (filled triangles) and control TAP° (open triangles) splenocytes (left panel). VSV-specific CTL were incubated with ss-VSV (filled circles) and control B6 (open circles) splenocytes (right panel). Peptide-specific CTL (5 × 104) were cultured with increasing numbers of irradiated APC for 72 hr and were pulsed with [3H]thymidine for 18 hr. Immunity 1999 11, 183-190DOI: (10.1016/S1074-7613(00)80093-X)

Figure 3 Proliferation of OT-1 CD8+ T Cells in Irradiated TAP° Hosts Is Restored by Expression of an Antagonist Peptide Donor cells were pooled spleen and lymph node from OT-1 (A) or OT-1 RAG° mice (B). CD8+Vα2+ CFSE-labeled cells (2 × 106) were injected per indicated host. CFSE expression is shown for CD8+Vα2+ cells from spleen on day 5 (A) or day 6 (B) post transfer. Data are representative of at least five experiments. Immunity 1999 11, 183-190DOI: (10.1016/S1074-7613(00)80093-X)

Figure 4 Exogenous R4 and ss-R4 Transgene-Expressing Cells Do Not Stimulate Proliferation or CTL Targeting by OT-1 CD8+ T cells (A) OT-1 splenocytes were cultured with OVAp (circles), R4 (diamonds), or VSV (squares) peptides and irradiated B6 splenocytes and were pulsed with [3H]thymidine for 6 hr after 36 hr of culture. (B) OT-1 CTL were used at 10:1 effector to target ratio with OVAp (circles), R4 (diamonds), or VSV (squares) peptide coated and EL4 target cells. (C) OT-1 splenocytes were cultured with increasing numbers of irradiated splenocytes from the following mice: ss-OVATAP° (circles), B6 (triangles), ss-R4TAP° line 1 (open diamonds), ss-R4TAP° line 2 (filled diamonds), and ss-VSVTAP° (squares). The assay was pulsed with [3H]thymidine for 18 hr after 36 hr of culture. (D) OT-1 CTL were used at the indicated effector to target ratio with 51Cr-labeled Con A blasts as targets made from the following mice: ss-OVATAP° (circles), TAP° (triangles), ss-R4TAP° line 1 (open diamonds), and ss-VSVTAP° (squares). Immunity 1999 11, 183-190DOI: (10.1016/S1074-7613(00)80093-X)

Figure 5 Surface Phenotype of CD8+ T Cells Proliferating in Various Hosts CD8+Vα2+ cells (2 × 106) from OT-1 RAG° mice were CFSE labeled, injected into irradiated hosts, and splenocytes were analyzed 6 days post transfer. (A) This panel shows Vα2 versus CFSE levels for CD8+ cells transferred into irradiated TAP°, B6, ss-R4TAP°, and ss-OVApTAP° hosts. (B) This panel compares levels of activation markers on the transferred OT-1 CD8+ T cells. Donor cells were gated on CD8+Vα2+ from TAP° (bold gray line), B6 (thin black line), ss-R4TAP° (dotted line), and ss-OVApTAP° (bold black line). Similar results were obtained 4 and 7 days post transfer. Immunity 1999 11, 183-190DOI: (10.1016/S1074-7613(00)80093-X)

Figure 6 OT-1 Cells Proliferating in Irradiated B6 and ss-R4TAP° Mice Do Not Become Cytotoxic Effector Cells CD8+Vα2+ cells (2 × 106) from OT-1 RAG° mice were CFSE labeled and injected into irradiated B6 (triangles), ss-R4TAP° (diamonds), or ss-OVApTAP° (circles) hosts. Spleen cells were harvested on day 4 and assayed for lysis of OVAp-coated EL4 targets. Flow cytometry revealed that transferred OT-1 Vα2+CD8+ cells represented 15%, 6%, and 75% of splenocytes recovered from B6, ss-R4TAP°, or ss-OVApTAP° hosts, respectively (data not shown). The E:T was based on the number of CD8+Vα2+ cells used as effectors. The wells were normalized for total cell number by diluting cells recovered from B6 (triangles) and ss-OVApTAP° hosts (filled circles) with fresh B6 splenocytes to 6% CD8+Vα2+ cells, or cells recovered from ss-OVApTAP° hosts were used undiluted (open circles). For all effectors at all E:T ratios, lysis of EL4 targets in the absence of peptide was less than 3% (data not shown). Immunity 1999 11, 183-190DOI: (10.1016/S1074-7613(00)80093-X)